IP Library Granted Patent US 10,137,168
Granted Patent B2
US 10,137,168 · App. 14/258,197 · Granted Nov 27, 2018

Veterinary decorin compositions and use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,137,168
App. No.
14/258,197
Granted
Nov 27, 2018
Kind
B2
Abstract

The present invention relates to veterinary decorin compositions and methods of their production.

Claims (6)

1. A veterinary decorin core protein molecule that is at least 98% identical to one of SEQ ID NOs:4, 7, 10, 13, 16, 19, 22, and 27, wherein the veterinary core protein molecule comprises an aspartic acid residue at the N-terminus and does not comprise a serine residue at the fourth amino acid from the N-terminus.

2. The veterinary decorin core protein molecule of claim 1 , wherein said protein molecule is at least 99% identical to one of SEQ ID NOs:4, 7, 10, 13, 16, 19, 22, and 27, wherein the veterinary core protein molecule comprises an aspartic acid residue at the N-terminus and does not comprise a serine residue at the fourth amino acid from the N-terminus.

3. The veterinary decorin core protein molecule of claim 1 , wherein said protein molecule is 100% identical to one of SEQ ID NOs:4, 7, 10, 13, 16, 19, 22, and 27.

4. The veterinary decorin core protein molecule of claim 1 , wherein said core molecule is operably linked to a signal peptide that is exogenous to said veterinary decorin core protein molecule.

5. The veterinary decorin core protein molecule of claim 4 , wherein said signal peptide is a bovine lactalbumin signal peptide.

6. A composition comprising a veterinary decorin core protein molecule according to claim 1 in combination with a pharmaceutically acceptable carrier.

Assignments (3)
SECURITY INTEREST Recorded Dec 19, 2024
From: CATALENT CTS (KANSAS CITY), LLC; REDWOOD BIOSCIENCE, INC.; R.P. SCHERER TECHNOLOGIES, LLC; CATALENT WELLNESS, LLC; CATALENT PHARMA SOLUTIONS, INC.; CATALENT WELLNESS NEW JERSEY, LLC; CATALENT MARYLAND, INC.; CATALENT GREENVILLE, INC.; CATALENT MICRON TECHNOLOGIES, INC.; CATALENT SAN DIEGO, INC.; CATALENT WELLNESS VIRGINIA, LLC; CATALENT USA PACKAGING, LLC; CATALENT PHARMA SOLUTIONS, LLC
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 069743/0458 →
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL (049221/0673) Recorded Dec 19, 2024
From: JPMORGAN CHASE BANK, N.A.
To: CATALENT PHARMA SOLUTIONS, LLC; R.P. SCHERER TECHNOLOGIES, INC.; R.P. SCHERER TECHNOLOGIES, LLC; REDWOOD BIOSCIENCE, INC.
Reel/Frame 069751/0100 →
SUPPLEMENTAL SECURITY AGREEMENT Recorded May 20, 2019
From: R.P. SCHERER TECHNOLOGIES, LLC; CATALENT PHARMA SOLUTIONS, LLC; REDWOOD BIOSCIENCE, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 049221/0673 →